76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Jazz Pharmaceuticals PLC
Closed
SectorHealthcare
111.16 2.67
Overview
Share price change
24h
Min
108.32
Max
111.8
Income | -284M -93M |
|---|---|
Sales | -190M 898M |
P/E Sector Avg | 14.713 51.198 |
EPS | 1.68 |
Profit margin | -10.307 |
Employees | 2,800 |
EBITDA | -275M 109M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +68.8% upside |
Next Earnings | 30 Jul 2025 |
|---|
Market Cap | -725M 6.7B |
|---|---|
Previous open | 108.49 |
Previous close | 111.16 |
News Sentiment
By Acuity
50%
50%
167 / 380 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Jazz Pharmaceuticals PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Jazz Pharmaceuticals PLC Forecast
Price Target
By TipRanks
68.8% upside
12 Months Forecast
Average 184.75 USD 68.8%
High 220 USD
Low 147 USD
Based on 13 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.
Sentiment
By Acuity
167 / 380 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
